| Melissa Kay Zupancic, NP | |
|
864 Knightsbridge Dr, Akron, OH 44313 | |
| (330) 328-1430 | |
| Not Available |
| Full Name | Melissa Kay Zupancic |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 864 Knightsbridge Dr, Akron, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023127040 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Kay Zupancic, NP 864 Knightsbridge Dr, Akron, OH 44313 Ph: (330) 328-1430 | Melissa Kay Zupancic, NP 864 Knightsbridge Dr, Akron, OH 44313 Ph: (330) 328-1430 |
News Archive
A study led by the Barcelona Institute for Global Health (ISGlobal) - an institution supported by "la Caixa" Foundation- reveals a new mechanism by which the malaria parasite Plasmodium falciparum converts from its asexual to its sexual form, which can be transmitted to the mosquito.
At a press conference held today at The Endocrine Society's 91st Annual Meeting in Washington, D.C., Nelly Mauras, M.D., Division Chief of Endocrinology at Nemours Children's Clinic in Jacksonville, announced the results of a four year study with findings that show childhood obesity increases early signs of cardiovascular disease. Dr. Mauras' study was chosen for distinction among 5,000 abstracts that were submitted to the national conference.
Only one in twenty cancer drugs makes its way from the laboratory to become an approved pharmaceutical product. The majority of new agents are only shown to be unsuitable in the later phases of clinical development which would explain the exorbitantly high development costs of 500 to 600 million euros per new cancer drug.
New results from a safety and immunogenicity study, which included a challenge phase to test efficacy, indicate that a live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine candidate, given in combination with a novel adjuvant, provided significant protection against disease.
Scientists at UC San Francisco have developed a test to predict a woman's risk of preterm birth when she is between 15 and 20 weeks pregnant, which may enable doctors to treat them early and thereby prevent severe complications later in the pregnancy.
› Verified 7 days ago
Shakeilah Carelle Burns, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1949 W Market St, Akron, OH 44313 Phone: 866-389-2727 | |
Felicia Zabala, APRN. CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-5995 | |
Mrs. Molly A. Hockin, MSN, APRN, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 340 S Broadway St, Akron, OH 44308 Phone: 330-253-3100 | |
Sarah Elizabeth Bailey, CNP-APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 444 W Exchange St, Akron, OH 44302 Phone: 330-535-2671 | |
Heather Larson, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-6060 Fax: 330-543-6069 | |
Mrs. Erika Lynn Gross, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 224 W Exchange St, Suite 160, Akron, OH 44302 Phone: 330-344-6505 | |
Lisa Young, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 |